There were 1,700 press releases posted in the last 24 hours and 447,277 in the last 365 days.

Puration Wraps Arnold Sports Festival With New Orders, Opportunities and Partnerships

DALLAS, March 04, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Puration, Inc. (USOTC: PURA) today announced a presentation scheduled for Thursday this week, March 7th, 2019, to review new orders, opportunities and partnerships stemming from the EVERx CBD Sports Water event this past weekend at the Arnold Sports Festival.  “We got our tires kicked at the Arnold by some very large distributors that would substantially change our trajectory,” said Brian Shibley, CEO of PURA.  EVERx CBD Sports Water debuted it’s all new formula and packaging at the world-renowned Arnold Sports Festival this week in Columbus, Ohio, where EVERx launched for the first time ever in 2017.

Arnold Sports Festival Award Presentation Models
PURA PR March 4


Analyst Speculative Buy Recommendation and $0.25 PPS Target with $0.35 Upside

Goldman Small Cap Research issued a research update on Puration, Inc. (USOTC: PURA) last week recommending a 'speculative-buy' rating with a target price-per-share of $0.25, with noted potential upside to the $0.35 mark

For more information on Puration, visit http://www.purationinc.com

Disclaimer/Safe Harbor: 

This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/48fcc68b-84cb-4a6b-b80d-cc655e12d0b8

PURA.png

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.